LESLEY HANDJIS: Open Payments
NPI 1780075077 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$369 in 19 payments from 10 companies in 2025. Trend: 2023 $18 · 2024 $400 · 2025 $369
Food & beverage: $369
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $72 |
| ABBVIE INC. | 3 | $61 |
| Novo Nordisk Inc | 3 | $53 |
| Ardelyx, Inc. | 2 | $49 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Dexcom, Inc. | 1 | $25 |
| Tris Pharma Inc | 1 | $21 |
| Tonix Medicines, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: Kerendia, QULIPTA, IBSRELA, Auvelity, Ozempic, Dexcom G6 Transmitter, Dyanavel XR, Wegovy.
Industry payments across AL — which companies pay providers there.
